Recommended for Intellectual Property: Patent Litigation: Full Coverage
The Legal 500 US 2019
Profile
Dr. Ernest Yakob advises major life sciences companies on matters related to patent and intellectual property litigation, drawing on years of experience in both the lab and the law.
Ernest handles patent disputes for life sciences companies in district courts, as well as inter partes review and post-grant review proceedings before the US Patent and Trademark Office. He also routinely advises clients on a wide range of IP matters, including patent prosecution and opinions, as well as IP licensing and due diligence.
As a registered patent attorney with a doctorate in microbiology and immunology as well as complementary academic degrees in chemical engineering and molecular biology, Ernest advises clients with a sophisticated understanding of the underlying products.
Experience
Ernest's experience includes advising:
Merck in patent infringement and trade secret misappropriation suits adverse to Pfizer, and inter partes review and post-grant review proceedings adverse to Pfizer and GSK, relating to pneumococcal vaccines*
Merck Animal Health and Kansas State University Research Foundation in district court litigation and post-grant review proceeding adverse to Boehringer Ingelheim Animal Health involving porcine circovirus 3 patent
Biogen and Alkermes in Hatch-Waxman litigation relating to multiple sclerosis drug
BASF in patent infringement suit relating to omega-3 fatty acids*
Santen Pharmaceutical, Asahi Glass, and Oak Pharmaceuticals in Hatch-Waxman litigation and inter partes review involving glaucoma drugs*
Depomed, Inc. in patent infringement suit and inter partes reviews relating to Depomed’s innovative gastric retentive drug technology*
Penford Corporation in patent infringement suit relating to phosphorylated resistant starches*
*Matter handled prior to joining Latham
Qualifications
Bar Qualification
New York
US Patent and Trademark Office
Education
PhD, Albert Einstein College of Medicine, 2015
BS, Columbia School of Engineering and Applied Science, 1999
Latham's Intellectual Property Litigation Practice was honored for securing exceptional trial results this year, including a complete jury trial win for Sarepta Therapeutics and an ITC trial win for Netgear.
A Latham team led by Mike Morin and David Frazier won the “Litigators of the Week” competition, alongside co-counsel at Finnegan, for their outstanding defense against a US$290 million patent infringement claim and securing a US$116 million award on behalf of Sarepta Therapeutics, in a one-week timed trial in Delaware.
Our Intellectual Property Litigation practice received this prestigious award for securing a number of successes over the past year “on all fronts across the spectrum of IP disputes and jurisdictions from coast to coast."
Latham secured a US$115 million verdict for Sarepta Therapeutics and the University of Western Australia in a patent infringement claim against Nippon Shinyaku.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.